A Novel Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor, Crisaborole Ointment, Reduced Pruritus and Signs of Atopic Dermatitis in 2 Phase 3 Studies in Children and Adults

2018 ◽  
Author(s):  
Adelaide A. Hebert ◽  
Lawrence F. Eichenfield ◽  
Mark G. Lebwohl ◽  
Amy S. Paller ◽  
Eric L. Simpson ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Phase 3 ◽  
Phosphodiesterase 4 ◽  
Anti Inflammatory ◽  
Phosphodiesterase 4 Inhibitor

Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis

1999 ◽  
Vol 145 (7) ◽  
pp. 191-194 ◽  
Author(s):  
L. Ferrer ◽  
J. Alberola ◽  
M. Queralt ◽  
P. Brazis ◽  
R. Rabanal ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Phosphodiesterase 4 ◽  
Anti Inflammatory ◽  
Phosphodiesterase 4 Inhibitor

scholarly journals 286 Phase 3 studies in atopic dermatitis with the novel, nonsteroidal topical phosphodiesterase 4 inhibitor, crisaborole

2016 ◽  
Vol 136 (5) ◽  
pp. S50 ◽  
Author(s):  
A.S. Paller ◽  
W.L. Tom ◽  
R.S. Call ◽  
L. Eichenfield ◽  
D. Forsha ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
The Novel ◽  
Phase 3 ◽  
Phosphodiesterase 4 ◽  
Phosphodiesterase 4 Inhibitor
Sign in / Sign up

Export Citation Format

Share Document